Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire

Halimi JM, Sarafidis P, Azizi M, Bilo G, Burkard T, Bursztyn M, Camafort M, Chapman N, Cottone S, de Backer T, Deinum J, Delmotte P, Dorobantu M, Doumas M, Dusing R, Duly-Bouhanick B, Fauvel JP, Fesler P, Gaciong Z, Gkaliagkousi E, Gordin D, Grassi G, Grassos C, Guerrot D, Huart J, Izzo R, Aguila FJ, Jarai Z, Kahan T, Kantola I, Kocianov E, Limbourg FP, Lopez-Sublet M, Mallamaci F, Manolis A, Marketou M, Mayer G, Mazza A, MacIntyre IM, Mourad JJ, Muiesan ML, Nasr E, Nilsson P, Oliveras A, Ormezzano O, Paixão-Dias V, Papadakis I, Papadopoulos D, Perl S, Polonia J, Pontremoli R, Pucci G, Robles NR, Rubin S, Ruilope LM, Rump LC, Saeed S, Sanidas E, Sarzani R, Schmieder R, Silhol F, Sokolovic S, Solbu M, Soucek M, Stergiou G, Sudano I, Tabbalat R, Tengiz I, Triantafyllidi H, Tsioufis K, Vaclav J, van der Giet M, Van der Niepen P, Veglio F, Venzin RM, Viigimaa M, Weber T, Widimsky J, Wuerzner G, Zelveian P, Zebekakis P, Lueders S, Persu A, Kreutz R, Vogt L (2024)

Publication Type: Journal article

Publication year: 2024

Journal

Book Volume: 42

Pages Range: 1544-1554

Journal Issue: 9

DOI: 10.1097/HJH.0000000000003756

Abstract

Objective: Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. Methods: A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management of CKD patients referred to ESH-Hypertension Excellence Centres (ESH-ECs) at first referral visit. The questionnaire contained 64 questions with which ESH-ECs representatives were asked to estimate preexisting CKD management quality. Results: Overall, 88 ESH-ECs from 27 countries participated (fully completed surveys: 66/88 [75.0%]). ESH-ECs reported that 28% (median, interquartile range: 15–50%) had preexisting CKD, with 10% of them (5–30%) previously referred to a nephrologist, while 30% (15–40%) had resistant hypertension. The reported rate of previous recent (<6months) estimated glomerular filtration rate (eGFR) and urine albumin–creatinine ratio (UACR) testing were 80% (50–95%) and 30% (15–50%), respectively. The reported use of renin-angiotensin system blockers was 80% (70–90%). When a nephrologist was part of the ESH-EC teams the reported rates SGLT2 inhibitors (27.5% [20 – 40%] vs. 15% [10 – 25], P ¼ 0.003), GLP1-RA (10% [10 – 20%] vs. 5% [5 – 10%], P ¼ 0.003) and mineralocorticoid receptor antagonists (20% [10 – 30%] vs. 15% [10 – 20%], P ¼ 0.05) use were greater as compared to ESH-ECs without nephrologist participation. The rate of reported resistant hypertension, recent eGFR and UACR results and management of CKD patients prior to referral varied widely across countries. Conclusions: Our estimation indicates deficits regarding CKD screening, use of nephroprotective drugs and referral to nephrologists before referral to ESH-ECs but results varied widely across countries. This information can be used to build specific programs to improve care in hypertensives with CKD.

Authors with CRIS profile

Involved external institutions

Consiglio Nazionale delle Ricerche (CNR) / National Research Council of Italy Italy (IT) University General Hospital of Heraklion Greece (GR) Hospital Center University Rouen / Centre hospitalier universitaire de Rouen (CHU) France (FR) Centre Hospitalier Universitaire de Liège (CHU Liège) Belgium (BE) Università degli Studi di Napoli Federico II Italy (IT) Complejo Hospitalario Universitario de Granada Spain (ES) St. Imre Teaching Hospital Hungary (HU) Karolinska Institute Sweden (SE) Turku University Hospital / Turun yliopistollinen keskussairaala (TYKS) Finland (FI) Hôpital Bretonneau France (FR) Medizinische Hochschule Hannover (MHH) / Hannover Medical School Germany (DE) St. Anne's University Hospital / Sv. Anny v Brně Czech Republic (CZ) Western General Hospital United Kingdom (GB) Universitätsspital Zürich (USZ) Switzerland (CH) Abdali Hospital Jordan (JO) Hôpital Franco-Britannique France (FR) Università degli Studi di Brescia Italy (IT) Saint George Hospital University Medical Center Lebanon (LB) Lund University / Lunds universitet Sweden (SE) Universitat Pompeu Fabra (UPF) Spain (ES) Hôpital Albert Michallon France (FR) Centro Hospitalar de Vila Nova de Gaia Portugal (PT) Laikο General Hospital of Athens Greece (GR) Medizinische Universität Graz Austria (AT) Ospedale Policlinico San Martino Italy (IT) Università degli Studi di Perugia Italy (IT) Centre Hospitalier Universitaire de Bordeaux / CHU Bordeaux France (FR) Heinrich-Heine-Universität Düsseldorf Germany (DE) Haukeland University Hospital / Haukeland universitetssykehus Norway (NO) Università Politecnica delle Marche (UNIVPM) / Marche Polytechnic University Italy (IT) Hôpital de la Timone France (FR) Plava Medical Group Bosnia And Herzegovina (BA) University Hospital of North Norway / Universitetssykehuset Nord-Norge (UNN) Norway (NO) National and Kapodistrian University of Athens Greece (GR) University Hospital Ostrava / Fakultní Nemocnice Ostrava Czech Republic (CZ) Charité - Universitätsmedizin Berlin Germany (DE) Universitair Ziekenhuis Brussel Belgium (BE) University of Turin / Università degli Studi di Torino (UNITO) Italy (IT) Kantonsspital Graubünden Switzerland (CH) Tallinn University of Technology Estonia (EE) Klinikum Wels-Grieskirchen Austria (AT) Lausanne University Hospital / Centre hospitalier universitaire vaudois (CHUV) Switzerland (CH) Aristotle University of Thessaloniki Greece (GR) St. Josefs-Hospital Cloppenburg gemeinnützige GmbH Germany (DE) Cliniques universitaires Saint-Luc (CHU St-Luc) Belgium (BE) General Hospital of Attica (KAT) / γενικο νοσοκομειο αττικης Greece (GR) Avicenne Hospital / Hôpital Avicienne France (FR) Metropolitan Hospital Greece (GR) Medicana International Izmir Hospital Turkey (TR) Université Sorbonne Paris Cité France (FR) Instituto Auxologico Italiano Italy (IT) Universitätsspital Basel Switzerland (CH) Hadassah Medical Center / מרכז רפואי הדסה‎‎ Israel (IL) Universitat de Barcelona (UB) / University of Barcelona Spain (ES) Imperial College Healthcare NHS Trust United Kingdom (GB) Policlinico Universitario Paolo Giaccone Italy (IT) University Hospital Ghent Belgium (BE) Radboud University Nijmegen Medical Centre / Radboudumc of voluit Radboud Universitair Medisch Centrum (UMC) Netherlands (NL) European Society of Hypertension (ESH) Italy (IT) Bucharest Emergency University Hospital Romania (RO) Université Fédérale de Toulouse Midi-Pyrénées France (FR) Hôpital Edouard Herriot France (FR) Centre Hospitalier Universitaire de Montpellier (CHU/CHRU MTP) France (FR) Wrocław Medical University / Uniwersytet Medyczny we Wrocławiu Poland (PL) Helsinki University Central Hospital (HUCH) / Helsingin seudun yliopistollinen keskussairaala (HYKS) Finland (FI) Medizinische Universität Innsbruck Austria (AT) General University Hospital in Prague / Všeobecná Fakultní Nemocnice v Praze (VFN) Czech Republic (CZ) Amsterdam University Medical Centers (Amsterdam UMC) / Amsterdam Universitair Medische Centra Netherlands (NL) University of Milano-Bicocca / Università degli Studi di Milano-Bicocca, UNIMIB Italy (IT)

How to cite

APA:

Halimi, J.M., Sarafidis, P., Azizi, M., Bilo, G., Burkard, T., Bursztyn, M.,... Vogt, L. (2024). Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire. Journal of Hypertension, 42(9), 1544-1554. https://doi.org/10.1097/HJH.0000000000003756

MLA:

Halimi, Jean Michel, et al. "Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire." Journal of Hypertension 42.9 (2024): 1544-1554.

BibTeX: Download